Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme.
Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
Quantitative structure-activity relationship studies on sulfonamide-based MMP inhibitors.
Optic Neuritis Probably Induced by Isotretinoin.
Targeting IRF4 in autoimmune diseases.
Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis.
Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Aquaporins: important but elusive drug targets.
Yoga for multiple sclerosis: a systematic review and meta-analysis.
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases.
Haplotypes across the human caveolin 1 gene upstream purine complex significantly alter gene expression: Implication in neurodegenerative disorders.
Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain.
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
Cyclophosphamide so-so verdict in progressive MS
Structure and signalling in the IL-17 receptor family.
Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis.
ICV-transplanted human glial precursor cells are short-lived yet exert immunomodulatory effects in mice with EAE.
Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy.
Discovery of Biologically Active Oncologic and Immunologic Small Molecule Therapies using Zebrafish: Overview and Example of Modulation of T Cell Activation.
Comparing routine neurorehabilitation program with trunk exercises based on Bobath concept in multiple sclerosis: Pilot study.
A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.

Pages